Chemo Pharma Laboratories has informed that the meeting of the Board of Directors of the Company is scheduled on 27/10/2023 to consider and approve the Un-Audited Financial Statements for the quarter and half year ended September 30, 2023 along with the Limited Review Report thereon.
The above information is a part of company’s filings submitted to BSE.